In her inaugural lecture on Wednesday 12th November, Dr Clare Gillies of the Department of Health Sciences will reveal the results of her simulation study investigating the clinical and cost implications of screening people ‘at risk’ for impaired glucose intolerance and type 2 diabetes mellitus.
An important outcome of the work by Dr Gillies shows that early treatment and intervention resulting from this screening is potentially a cost-effective health policy for the UK.
Dr. Gillies is the winner of the School of Medicine Lauder Prize for best PhD. The prize will be awarded at the end of her lecture which starts at 5.30pm in the Frank and Katherine May lecture theatre, Henry Wellcome Building.
Her research involved comparing the cost and health implications of four different approaches to screening for impaired glucose tolerance and type 2 diabetes. These were:
i) no screening
ii) screening for type 2 diabetes alone resulting in health benefits from early diagnosis and treatment of the disease
iii) screening for impaired glucose tolerance and type 2 diabetes, allowing for both early treatment of diabetes and for lifestyle interventions to be applied to individuals with impaired glucose tolerance to reduce their risk of developing diabetes
iv) as for iii) but with pharmacological rather than lifestyle interventions
Dr Gillies developed a computer decision model using data from a number of sources to evaluate the cost and health implications of these four policies.
She said: “The model simulated a population with an increased risk of developing type 2 diabetes, who were aged 45 at the start of the model and thus time of screening. The model was run to estimate the cost and health implications over a 50 year time horizon, and the four different screening policies were then compared.
“Conclusions drawn from the work were that screening for type 2 diabetes and impaired glucose tolerance, with appropriate interventions for the latter, in an above average risk population at age 45, appears to be cost effective.
“The cost effectiveness of a policy of screening for diabetes alone, which offered no intervention to those with impaired glucose tolerance, is still uncertain and more information is needed on the long term health implications of early diagnosis and treatment of this disease.”
• The work was funded jointly by the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC) as part of an interdisciplinary research initiative in the social and medical sciences.
Dr Clare Gillies is a medical statistician who has been based at the University of Leicester for 8 years, after gaining an MSc in medical statistics from the London School of Hygiene and Tropical Medicine in 2000. During this time she has worked on a number of projects including a Ph.D. investigating evidence synthesis methods for health policy decision making, with particular reference to policies concerning screening for type 2 diabetes mellitus. She joined the Ehleis project (European Health and Life Expectancy Information Systems) in 2007 and will be working on identifying factors associated with inequalities in healthy life years across EU member states, using a variety of datasets.
Dr. Clare Gillies is the winner of the School of Medicine Lauder Prize for best PhD. The prize will be awarded at the end of her lecture.
Ather Mirza | alfa
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy